Table 4. AEs experienced in primary... | American Society of Hematology

Table 4.

AEs experienced in primary cohort regardless of attribution

AE*	Patients with AEs of any grade		Patients with AEs grade 3 to 4
AE*	No.	%	No.	%
Hematologic laboratory event
Anemia	6	67	3	33
Thrombocytopenia	3	33	2	22
Leukopenia	3	33	1	11
Lymphopenia	3	33	2	22
Decreased WBCs	2	22	2	22
Nonhematologic laboratory event
Increased aspartate aminotransferase (AST)	3	33	0	0
Hyperglycemia	3	33	2	22
Hyperuricemia	3	33	1	11
Hypoalbuminemia	3	33	0	0
Increased alkaline phosphatase (ALP)	2	22	0	0
Hypocalcemia	2	22	0	0
Hypernatremia	2	22	0	0
Clinical event
Cough	5	56	0	0
Fatigue	5	56	0	0
Dyspnea	4	44	1	11
Chest pain	3	33	0	0
Diarrhea	3	33	0	0
Dizziness	3	33	0	0
Fever	3	33	0	0
Headache	3	33	1	11
Nausea	3	33	0	0
Weakness	3	33	1	11
Blurred vision	2	22	0	0
Constipation	2	22	0	0
Dyspepsia	2	22	0	0
Productive cough	2	22	0	0
Rash	2	22	0	0
Sore throat	2	22	0	0
Upper respiratory infection	2	22	0	0
Weight loss	2	22	0	0

AE*	Patients with AEs of any grade		Patients with AEs grade 3 to 4
AE*	No.	%	No.	%
Hematologic laboratory event
Anemia	6	67	3	33
Thrombocytopenia	3	33	2	22
Leukopenia	3	33	1	11
Lymphopenia	3	33	2	22
Decreased WBCs	2	22	2	22
Nonhematologic laboratory event
Increased aspartate aminotransferase (AST)	3	33	0	0
Hyperglycemia	3	33	2	22
Hyperuricemia	3	33	1	11
Hypoalbuminemia	3	33	0	0
Increased alkaline phosphatase (ALP)	2	22	0	0
Hypocalcemia	2	22	0	0
Hypernatremia	2	22	0	0
Clinical event
Cough	5	56	0	0
Fatigue	5	56	0	0
Dyspnea	4	44	1	11
Chest pain	3	33	0	0
Diarrhea	3	33	0	0
Dizziness	3	33	0	0
Fever	3	33	0	0
Headache	3	33	1	11
Nausea	3	33	0	0
Weakness	3	33	1	11
Blurred vision	2	22	0	0
Constipation	2	22	0	0
Dyspepsia	2	22	0	0
Productive cough	2	22	0	0
Rash	2	22	0	0
Sore throat	2	22	0	0
Upper respiratory infection	2	22	0	0
Weight loss	2	22	0	0

All AEs that occurred in at least 2 treated patients.